Literature DB >> 34714383

Cytokine profiles of macular neovascularization in the elderly based on a classification from a pachychoroid/drusen perspective.

Satoru Inoda1, Hidenori Takahashi2,3, Yuji Inoue1, Xue Tan4, Hironobu Tampo1, Yusuke Arai1, Yasuo Yanagi1,5, Hidetoshi Kawashima1.   

Abstract

PURPOSE: To classify macular neovascularization (MNV) based on pachychoroid and drusen features and to examine the aqueous humor cytokine signatures of each group.
METHODS: In total, 106 consecutive eyes with treatment-naïve MNV and 104 control eyes were examined. The aqueous humor concentrations of 15 cytokines were compared among the MNV groups classified based on the presence of drusen and/or pachychoroid features. Multidimensional scaling analysis was used to visualize the similarity level of the MNV subtypes according to their cytokine profiles.
RESULTS: Thirty-one, 18, 43, and 10 eyes were classified into the pachychoroid-associated, drusen-associated, pachychoroid/drusen-associated, and non-drusen/non-pachychoroid MNV groups, respectively. Compared with the control group, cytokines were differently upregulated among the MNV groups. CRP and CXCL12 were significantly upregulated in all MNV groups, whereas CXCL13 and IL-8 were significantly upregulated in three MNV groups, excluding the non-pachychoroid/non-drusen-associated MNV group. Ang-2 was significantly upregulated in three MNV groups except the drusen-associated MNV group. PlGF was significantly upregulated in the pachychoroid-associated and drusen-associated MNV groups. CCL-2 was significantly upregulated in the pachychoroid-associated and pachychoroid/drusen-associated MNV groups. VEGF was downregulated in the pachychoroid-associated and drusen-associated MNV groups, respectively. Multidimensional scaling analysis showed a distinct cytokine profile for each MNV group.
CONCLUSION: All MNV groups showed distinct cytokine profiles. Eyes with "neovascular age-related macular degeneration with drusen and concomitant pachychoroid" may share a similar etiology to those with "pachychoroid neovasculopathy" and "choroidal neovascularization with drusen," but have a distinct etiology to those without these. These findings suggest the importance of evaluating drusen and the choroid during the diagnosis of neovascular age-related macular degeneration.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Age-related macular degeneration; Choroidal neovascularization; Drusen; Inflammatory cytokines; Pachychoroid

Mesh:

Substances:

Year:  2021        PMID: 34714383     DOI: 10.1007/s00417-021-05445-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  35 in total

1.  Polypoidal Choroidal Vasculopathy: A Distinct Disease or Manifestation of Many?

Authors:  Chandrakumar Balaratnasingam; Won-Ki Lee; Hideki Koizumi; Kunal Dansingani; Maiko Inoue; K Bailey Freund
Journal:  Retina       Date:  2016-01       Impact factor: 4.256

2.  Pachychoroid neovasculopathy.

Authors:  Claudine E Pang; K Bailey Freund
Journal:  Retina       Date:  2015-01       Impact factor: 4.256

3.  DISEASE EXPRESSION IN NONEXUDATIVE AGE-RELATED MACULAR DEGENERATION VARIES WITH CHOROIDAL THICKNESS.

Authors:  Richard F Spaide
Journal:  Retina       Date:  2018-04       Impact factor: 4.256

Review 4.  An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group.

Authors:  A C Bird; N M Bressler; S B Bressler; I H Chisholm; G Coscas; M D Davis; P T de Jong; C C Klaver; B E Klein; R Klein
Journal:  Surv Ophthalmol       Date:  1995 Mar-Apr       Impact factor: 6.048

5.  Pachychoroid pigment epitheliopathy.

Authors:  David J Warrow; Quan V Hoang; K Bailey Freund
Journal:  Retina       Date:  2013-09       Impact factor: 4.256

6.  Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and Type 1 neovascular age-related macular degeneration.

Authors:  Hidetaka Matsumoto; Takashi Hiroe; Masahiro Morimoto; Kensuke Mimura; Arisa Ito; Hideo Akiyama
Journal:  Jpn J Ophthalmol       Date:  2018-02-06       Impact factor: 2.447

7.  [Classification and diagnostic criteria of age-related macular degeneration].

Authors:  Kanji Takahashi; Tatsuro Ishibashi; Yuichiro Ogur; Mitsuko Yuzawa
Journal:  Nippon Ganka Gakkai Zasshi       Date:  2008-12

8.  Clinical characteristics of exudative age-related macular degeneration in Japanese patients.

Authors:  Ichiro Maruko; Tomohiro Iida; Masaaki Saito; Dai Nagayama; Kuniharu Saito
Journal:  Am J Ophthalmol       Date:  2007-05-23       Impact factor: 5.258

9.  Pachychoroid neovasculopathy and age-related macular degeneration.

Authors:  Masahiro Miyake; Sotaro Ooto; Kenji Yamashiro; Ayako Takahashi; Munemitsu Yoshikawa; Yumiko Akagi-Kurashige; Naoko Ueda-Arakawa; Akio Oishi; Hideo Nakanishi; Hiroshi Tamura; Akitaka Tsujikawa; Nagahisa Yoshimura
Journal:  Sci Rep       Date:  2015-11-06       Impact factor: 4.379

10.  Distinct Aqueous Humour Cytokine Profiles of Patients with Pachychoroid Neovasculopathy and Neovascular Age-related Macular Degeneration.

Authors:  Nobuhiro Terao; Hideki Koizumi; Kentaro Kojima; Tetsuya Yamagishi; Yuji Yamamoto; Kengo Yoshii; Koji Kitazawa; Asako Hiraga; Munetoyo Toda; Shigeru Kinoshita; Chie Sotozono; Junji Hamuro
Journal:  Sci Rep       Date:  2018-07-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.